nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—NR3C1—epilepsy syndrome	0.366	1	CbGaD
Budesonide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0326	0.0879	CbGbCtD
Budesonide—CYP3A4—Trimethadione—epilepsy syndrome	0.0303	0.0817	CbGbCtD
Budesonide—CYP3A4—Felbamate—epilepsy syndrome	0.0303	0.0817	CbGbCtD
Budesonide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0285	0.0768	CbGbCtD
Budesonide—CYP3A4—Clonazepam—epilepsy syndrome	0.0257	0.0695	CbGbCtD
Budesonide—CYP3A4—Clobazam—epilepsy syndrome	0.0247	0.0666	CbGbCtD
Budesonide—CYP3A4—Rufinamide—epilepsy syndrome	0.021	0.0566	CbGbCtD
Budesonide—CYP3A4—Carbamazepine—epilepsy syndrome	0.0205	0.0552	CbGbCtD
Budesonide—CYP3A4—Primidone—epilepsy syndrome	0.0191	0.0515	CbGbCtD
Budesonide—CYP3A4—Phenytoin—epilepsy syndrome	0.0183	0.0495	CbGbCtD
Budesonide—CYP3A4—Propofol—epilepsy syndrome	0.0171	0.0462	CbGbCtD
Budesonide—CYP3A4—Phenobarbital—epilepsy syndrome	0.0164	0.0441	CbGbCtD
Budesonide—CYP3A4—Acetazolamide—epilepsy syndrome	0.0164	0.0441	CbGbCtD
Budesonide—CYP3A4—Midazolam—epilepsy syndrome	0.0161	0.0435	CbGbCtD
Budesonide—CYP3A4—Diazepam—epilepsy syndrome	0.0155	0.0418	CbGbCtD
Budesonide—CYP3A4—Zonisamide—epilepsy syndrome	0.0151	0.0408	CbGbCtD
Budesonide—CYP3A4—Valproic Acid—epilepsy syndrome	0.0122	0.033	CbGbCtD
Budesonide—CYP3A4—Topiramate—epilepsy syndrome	0.011	0.0297	CbGbCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SNIP1—epilepsy syndrome	0.000249	0.0415	CbGpPWpGaD
Budesonide—Prednisone—SLCO1A2—epilepsy syndrome	0.000223	0.0439	CrCbGaD
Budesonide—Prednisolone—SLCO1A2—epilepsy syndrome	0.000206	0.0404	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—FOSB—epilepsy syndrome	0.000194	0.0323	CbGpPWpGaD
Budesonide—Prednicarbate—NR3C1—epilepsy syndrome	0.000187	0.0368	CrCbGaD
Budesonide—Clocortolone—NR3C1—epilepsy syndrome	0.000187	0.0368	CrCbGaD
Budesonide—Diflorasone—NR3C1—epilepsy syndrome	0.000177	0.0348	CrCbGaD
Budesonide—Desonide—NR3C1—epilepsy syndrome	0.000177	0.0348	CrCbGaD
Budesonide—Desoximetasone—NR3C1—epilepsy syndrome	0.000173	0.034	CrCbGaD
Budesonide—Loteprednol—NR3C1—epilepsy syndrome	0.000171	0.0336	CrCbGaD
Budesonide—NR3C1—Endoderm Differentiation—DUSP5—epilepsy syndrome	0.000164	0.0274	CbGpPWpGaD
Budesonide—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000158	0.0264	CbGpPWpGaD
Budesonide—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000157	0.0309	CrCbGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—epilepsy syndrome	0.000156	0.026	CbGpPWpGaD
Budesonide—Flurandrenolide—NR3C1—epilepsy syndrome	0.000151	0.0297	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.000147	0.0246	CbGpPWpGaD
Budesonide—Hydrocortamate—NR3C1—epilepsy syndrome	0.000146	0.0288	CrCbGaD
Budesonide—Amcinonide—NR3C1—epilepsy syndrome	0.000136	0.0267	CrCbGaD
Budesonide—Mometasone—NR3C1—epilepsy syndrome	0.000129	0.0254	CrCbGaD
Budesonide—Rimexolone—NR3C1—epilepsy syndrome	0.000128	0.0251	CrCbGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—epilepsy syndrome	0.000128	0.0213	CbGpPWpGaD
Budesonide—Fluocinonide—NR3C1—epilepsy syndrome	0.000121	0.0237	CrCbGaD
Budesonide—Beclomethasone—NR3C1—epilepsy syndrome	0.000121	0.0237	CrCbGaD
Budesonide—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000118	0.0196	CbGpPWpGaD
Budesonide—Fluocinolone Acetonide—NR3C1—epilepsy syndrome	0.000117	0.0231	CrCbGaD
Budesonide—Alclometasone—NR3C1—epilepsy syndrome	0.000117	0.0231	CrCbGaD
Budesonide—Dexamethasone—SLCO1A2—epilepsy syndrome	0.000117	0.023	CrCbGaD
Budesonide—Flunisolide—NR3C1—epilepsy syndrome	0.000114	0.0224	CrCbGaD
Budesonide—Clobetasol propionate—NR3C1—epilepsy syndrome	0.000114	0.0224	CrCbGaD
Budesonide—Paramethasone—NR3C1—epilepsy syndrome	0.000113	0.0222	CrCbGaD
Budesonide—Ciclesonide—NR3C1—epilepsy syndrome	0.000111	0.0218	CrCbGaD
Budesonide—Triamcinolone—BCHE—epilepsy syndrome	0.000111	0.0217	CrCbGaD
Budesonide—Fluorometholone—NR3C1—epilepsy syndrome	0.00011	0.0216	CrCbGaD
Budesonide—NR3C1—Endoderm Differentiation—DUSP4—epilepsy syndrome	0.00011	0.0183	CbGpPWpGaD
Budesonide—Methylprednisolone—NR3C1—epilepsy syndrome	0.000106	0.0209	CrCbGaD
Budesonide—Dexamethasone—CYP11A1—epilepsy syndrome	0.000102	0.0201	CrCbGaD
Budesonide—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.000101	0.0169	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	9.82e-05	0.0164	CbGpPWpGaD
Budesonide—Triamcinolone—NR3C1—epilepsy syndrome	8.97e-05	0.0176	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—DUSP1—epilepsy syndrome	8.9e-05	0.0148	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	8.67e-05	0.0145	CbGpPWpGaD
Budesonide—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	8.61e-05	0.0144	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	8.46e-05	0.0141	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	8.46e-05	0.0141	CbGpPWpGaD
Budesonide—Dexamethasone—NOS2—epilepsy syndrome	8.46e-05	0.0166	CrCbGaD
Budesonide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	8.41e-05	0.014	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUND—epilepsy syndrome	8.28e-05	0.0138	CbGpPWpGaD
Budesonide—Prednisone—NR3C1—epilepsy syndrome	8.14e-05	0.016	CrCbGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—epilepsy syndrome	7.7e-05	0.0128	CbGpPWpGaD
Budesonide—Prednisolone—NR3C1—epilepsy syndrome	7.5e-05	0.0147	CrCbGaD
Budesonide—Ciclesonide—CYP2D6—epilepsy syndrome	7.5e-05	0.0147	CrCbGaD
Budesonide—Prednisone—CYP2C19—epilepsy syndrome	7.42e-05	0.0146	CrCbGaD
Budesonide—Betamethasone—NR3C1—epilepsy syndrome	7.35e-05	0.0144	CrCbGaD
Budesonide—NR3C1—Nuclear Receptors—VDR—epilepsy syndrome	7.29e-05	0.0121	CbGpPWpGaD
Budesonide—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	7.13e-05	0.0119	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK10—epilepsy syndrome	6.97e-05	0.0116	CbGpPWpGaD
Budesonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—epilepsy syndrome	6.9e-05	0.0115	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	6.76e-05	0.0113	CbGpPWpGaD
Budesonide—Hydrocortisone—ABCG2—epilepsy syndrome	6.65e-05	0.0131	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—RET—epilepsy syndrome	6.58e-05	0.011	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—MIF—epilepsy syndrome	6.53e-05	0.0109	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	6.41e-05	0.0107	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	6.31e-05	0.0105	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	6.07e-05	0.0101	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	5.87e-05	0.00978	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	5.87e-05	0.00978	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	5.76e-05	0.0096	CbGpPWpGaD
Budesonide—Hydrocortisone—NR3C1—epilepsy syndrome	5.74e-05	0.0113	CrCbGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	5.67e-05	0.00945	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	5.66e-05	0.00943	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	5.65e-05	0.00941	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUNB—epilepsy syndrome	5.63e-05	0.00939	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—AVP—epilepsy syndrome	5.61e-05	0.00935	CbGpPWpGaD
Budesonide—Dexamethasone—ABCC2—epilepsy syndrome	5.61e-05	0.011	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—TH—epilepsy syndrome	5.59e-05	0.00932	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	5.45e-05	0.00909	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	5.44e-05	0.00907	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	5.23e-05	0.00871	CbGpPWpGaD
Budesonide—Methylprednisolone—ABCB1—epilepsy syndrome	5.14e-05	0.0101	CrCbGaD
Budesonide—NR3C1—Circadian Clock—MEF2C—epilepsy syndrome	5.13e-05	0.00855	CbGpPWpGaD
Budesonide—Triamcinolone—PTGS2—epilepsy syndrome	5.09e-05	0.01	CrCbGaD
Budesonide—Hypertension—Pregabalin—epilepsy syndrome	5.04e-05	0.0002	CcSEcCtD
Budesonide—Vomiting—Diazepam—epilepsy syndrome	5.04e-05	0.0002	CcSEcCtD
Budesonide—Anorexia—Valproic Acid—epilepsy syndrome	5.02e-05	0.000199	CcSEcCtD
Budesonide—Tremor—Gabapentin—epilepsy syndrome	5.01e-05	0.000199	CcSEcCtD
Budesonide—Rash—Diazepam—epilepsy syndrome	4.99e-05	0.000198	CcSEcCtD
Budesonide—Dermatitis—Diazepam—epilepsy syndrome	4.99e-05	0.000198	CcSEcCtD
Budesonide—Visual impairment—Topiramate—epilepsy syndrome	4.98e-05	0.000198	CcSEcCtD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	4.98e-05	0.0083	CbGpPWpGaD
Budesonide—Myalgia—Pregabalin—epilepsy syndrome	4.97e-05	0.000197	CcSEcCtD
Budesonide—Chest pain—Pregabalin—epilepsy syndrome	4.97e-05	0.000197	CcSEcCtD
Budesonide—Arthralgia—Pregabalin—epilepsy syndrome	4.97e-05	0.000197	CcSEcCtD
Budesonide—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.96e-05	0.000197	CcSEcCtD
Budesonide—Dizziness—Zonisamide—epilepsy syndrome	4.96e-05	0.000197	CcSEcCtD
Budesonide—Headache—Diazepam—epilepsy syndrome	4.96e-05	0.000197	CcSEcCtD
Budesonide—Dexamethasone—ABCG2—epilepsy syndrome	4.96e-05	0.00974	CrCbGaD
Budesonide—Anxiety—Pregabalin—epilepsy syndrome	4.95e-05	0.000196	CcSEcCtD
Budesonide—Diarrhoea—Clonazepam—epilepsy syndrome	4.95e-05	0.000196	CcSEcCtD
Budesonide—Anaemia—Gabapentin—epilepsy syndrome	4.94e-05	0.000196	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.93e-05	0.000196	CcSEcCtD
Budesonide—Asthenia—Carbamazepine—epilepsy syndrome	4.92e-05	0.000195	CcSEcCtD
Budesonide—Agitation—Gabapentin—epilepsy syndrome	4.92e-05	0.000195	CcSEcCtD
Budesonide—Diarrhoea—Phenytoin—epilepsy syndrome	4.92e-05	0.000195	CcSEcCtD
Budesonide—Discomfort—Pregabalin—epilepsy syndrome	4.91e-05	0.000195	CcSEcCtD
Budesonide—Nausea—Fosphenytoin—epilepsy syndrome	4.9e-05	0.000195	CcSEcCtD
Budesonide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.89e-05	0.000194	CcSEcCtD
Budesonide—Angioedema—Gabapentin—epilepsy syndrome	4.89e-05	0.000194	CcSEcCtD
Budesonide—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.88e-05	0.000194	CcSEcCtD
Budesonide—Vomiting—Felbamate—epilepsy syndrome	4.87e-05	0.000193	CcSEcCtD
Budesonide—Dry mouth—Pregabalin—epilepsy syndrome	4.86e-05	0.000193	CcSEcCtD
Budesonide—Pruritus—Carbamazepine—epilepsy syndrome	4.85e-05	0.000192	CcSEcCtD
Budesonide—Rash—Felbamate—epilepsy syndrome	4.83e-05	0.000192	CcSEcCtD
Budesonide—Eye disorder—Topiramate—epilepsy syndrome	4.83e-05	0.000192	CcSEcCtD
Budesonide—Dermatitis—Felbamate—epilepsy syndrome	4.83e-05	0.000192	CcSEcCtD
Budesonide—Malaise—Gabapentin—epilepsy syndrome	4.82e-05	0.000191	CcSEcCtD
Budesonide—Vertigo—Gabapentin—epilepsy syndrome	4.81e-05	0.000191	CcSEcCtD
Budesonide—Headache—Felbamate—epilepsy syndrome	4.8e-05	0.000191	CcSEcCtD
Budesonide—Confusional state—Pregabalin—epilepsy syndrome	4.8e-05	0.00019	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.8e-05	0.00019	CcSEcCtD
Budesonide—Cardiac disorder—Topiramate—epilepsy syndrome	4.8e-05	0.00019	CcSEcCtD
Budesonide—Flushing—Topiramate—epilepsy syndrome	4.8e-05	0.00019	CcSEcCtD
Budesonide—Syncope—Gabapentin—epilepsy syndrome	4.8e-05	0.00019	CcSEcCtD
Budesonide—Dizziness—Clonazepam—epilepsy syndrome	4.78e-05	0.00019	CcSEcCtD
Budesonide—Nausea—Vigabatrin—epilepsy syndrome	4.78e-05	0.00019	CcSEcCtD
Budesonide—Vomiting—Zonisamide—epilepsy syndrome	4.77e-05	0.000189	CcSEcCtD
Budesonide—Insomnia—Valproic Acid—epilepsy syndrome	4.76e-05	0.000189	CcSEcCtD
Budesonide—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.76e-05	0.000189	CcSEcCtD
Budesonide—Asthenia—Lamotrigine—epilepsy syndrome	4.75e-05	0.000189	CcSEcCtD
Budesonide—Dizziness—Phenytoin—epilepsy syndrome	4.75e-05	0.000188	CcSEcCtD
Budesonide—Rash—Zonisamide—epilepsy syndrome	4.73e-05	0.000188	CcSEcCtD
Budesonide—Infection—Pregabalin—epilepsy syndrome	4.73e-05	0.000188	CcSEcCtD
Budesonide—Paraesthesia—Valproic Acid—epilepsy syndrome	4.73e-05	0.000188	CcSEcCtD
Budesonide—Palpitations—Gabapentin—epilepsy syndrome	4.73e-05	0.000188	CcSEcCtD
Budesonide—Dermatitis—Zonisamide—epilepsy syndrome	4.73e-05	0.000188	CcSEcCtD
Budesonide—Dizziness—Oxcarbazepine—epilepsy syndrome	4.73e-05	0.000187	CcSEcCtD
Budesonide—Nausea—Diazepam—epilepsy syndrome	4.7e-05	0.000187	CcSEcCtD
Budesonide—Loss of consciousness—Gabapentin—epilepsy syndrome	4.7e-05	0.000187	CcSEcCtD
Budesonide—Headache—Zonisamide—epilepsy syndrome	4.7e-05	0.000187	CcSEcCtD
Budesonide—Dyspnoea—Valproic Acid—epilepsy syndrome	4.7e-05	0.000186	CcSEcCtD
Budesonide—Diarrhoea—Carbamazepine—epilepsy syndrome	4.69e-05	0.000186	CcSEcCtD
Budesonide—Angiopathy—Topiramate—epilepsy syndrome	4.69e-05	0.000186	CcSEcCtD
Budesonide—Pruritus—Lamotrigine—epilepsy syndrome	4.69e-05	0.000186	CcSEcCtD
Budesonide—Shock—Pregabalin—epilepsy syndrome	4.68e-05	0.000186	CcSEcCtD
Budesonide—Somnolence—Valproic Acid—epilepsy syndrome	4.68e-05	0.000186	CcSEcCtD
Budesonide—Immune system disorder—Topiramate—epilepsy syndrome	4.67e-05	0.000185	CcSEcCtD
Budesonide—Nervous system disorder—Pregabalin—epilepsy syndrome	4.67e-05	0.000185	CcSEcCtD
Budesonide—Cough—Gabapentin—epilepsy syndrome	4.67e-05	0.000185	CcSEcCtD
Budesonide—Mediastinal disorder—Topiramate—epilepsy syndrome	4.66e-05	0.000185	CcSEcCtD
Budesonide—Tachycardia—Pregabalin—epilepsy syndrome	4.65e-05	0.000184	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	4.64e-05	0.00773	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	4.64e-05	0.00773	CbGpPWpGaD
Budesonide—Dyspepsia—Valproic Acid—epilepsy syndrome	4.64e-05	0.000184	CcSEcCtD
Budesonide—Skin disorder—Pregabalin—epilepsy syndrome	4.62e-05	0.000183	CcSEcCtD
Budesonide—Hypertension—Gabapentin—epilepsy syndrome	4.62e-05	0.000183	CcSEcCtD
Budesonide—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.6e-05	0.000183	CcSEcCtD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	4.6e-05	0.00767	CbGpPWpGaD
Budesonide—Vomiting—Clonazepam—epilepsy syndrome	4.6e-05	0.000182	CcSEcCtD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	4.59e-05	0.00765	CbGpPWpGaD
Budesonide—Decreased appetite—Valproic Acid—epilepsy syndrome	4.58e-05	0.000182	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	4.57e-05	0.00763	CbGpPWpGaD
Budesonide—Alopecia—Topiramate—epilepsy syndrome	4.57e-05	0.000181	CcSEcCtD
Budesonide—Vomiting—Phenytoin—epilepsy syndrome	4.57e-05	0.000181	CcSEcCtD
Budesonide—Rash—Clonazepam—epilepsy syndrome	4.56e-05	0.000181	CcSEcCtD
Budesonide—Dermatitis—Clonazepam—epilepsy syndrome	4.56e-05	0.000181	CcSEcCtD
Budesonide—Myalgia—Gabapentin—epilepsy syndrome	4.55e-05	0.000181	CcSEcCtD
Budesonide—Chest pain—Gabapentin—epilepsy syndrome	4.55e-05	0.000181	CcSEcCtD
Budesonide—Arthralgia—Gabapentin—epilepsy syndrome	4.55e-05	0.000181	CcSEcCtD
Budesonide—Nausea—Felbamate—epilepsy syndrome	4.55e-05	0.000181	CcSEcCtD
Budesonide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.55e-05	0.00018	CcSEcCtD
Budesonide—Vomiting—Oxcarbazepine—epilepsy syndrome	4.54e-05	0.00018	CcSEcCtD
Budesonide—Fatigue—Valproic Acid—epilepsy syndrome	4.54e-05	0.00018	CcSEcCtD
Budesonide—Anxiety—Gabapentin—epilepsy syndrome	4.54e-05	0.00018	CcSEcCtD
Budesonide—Anorexia—Pregabalin—epilepsy syndrome	4.54e-05	0.00018	CcSEcCtD
Budesonide—Dizziness—Carbamazepine—epilepsy syndrome	4.53e-05	0.00018	CcSEcCtD
Budesonide—Diarrhoea—Lamotrigine—epilepsy syndrome	4.53e-05	0.00018	CcSEcCtD
Budesonide—Headache—Clonazepam—epilepsy syndrome	4.53e-05	0.00018	CcSEcCtD
Budesonide—Rash—Phenytoin—epilepsy syndrome	4.53e-05	0.00018	CcSEcCtD
Budesonide—Mental disorder—Topiramate—epilepsy syndrome	4.53e-05	0.00018	CcSEcCtD
Budesonide—Dermatitis—Phenytoin—epilepsy syndrome	4.53e-05	0.00018	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.52e-05	0.000179	CcSEcCtD
Budesonide—Rash—Oxcarbazepine—epilepsy syndrome	4.51e-05	0.000179	CcSEcCtD
Budesonide—Pain—Valproic Acid—epilepsy syndrome	4.5e-05	0.000179	CcSEcCtD
Budesonide—Constipation—Valproic Acid—epilepsy syndrome	4.5e-05	0.000179	CcSEcCtD
Budesonide—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.5e-05	0.000179	CcSEcCtD
Budesonide—Headache—Phenytoin—epilepsy syndrome	4.5e-05	0.000179	CcSEcCtD
Budesonide—Malnutrition—Topiramate—epilepsy syndrome	4.5e-05	0.000179	CcSEcCtD
Budesonide—Discomfort—Gabapentin—epilepsy syndrome	4.5e-05	0.000179	CcSEcCtD
Budesonide—Headache—Oxcarbazepine—epilepsy syndrome	4.48e-05	0.000178	CcSEcCtD
Budesonide—Nausea—Zonisamide—epilepsy syndrome	4.46e-05	0.000177	CcSEcCtD
Budesonide—Dry mouth—Gabapentin—epilepsy syndrome	4.45e-05	0.000177	CcSEcCtD
Budesonide—Flatulence—Topiramate—epilepsy syndrome	4.43e-05	0.000176	CcSEcCtD
Budesonide—Tension—Topiramate—epilepsy syndrome	4.42e-05	0.000175	CcSEcCtD
Budesonide—Dysgeusia—Topiramate—epilepsy syndrome	4.41e-05	0.000175	CcSEcCtD
Budesonide—Confusional state—Gabapentin—epilepsy syndrome	4.4e-05	0.000175	CcSEcCtD
Budesonide—Dizziness—Lamotrigine—epilepsy syndrome	4.38e-05	0.000174	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—BMP4—epilepsy syndrome	4.37e-05	0.00729	CbGpPWpGaD
Budesonide—Nervousness—Topiramate—epilepsy syndrome	4.37e-05	0.000173	CcSEcCtD
Budesonide—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.37e-05	0.000173	CcSEcCtD
Budesonide—Vomiting—Carbamazepine—epilepsy syndrome	4.36e-05	0.000173	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	4.36e-05	0.00727	CbGpPWpGaD
Budesonide—Back pain—Topiramate—epilepsy syndrome	4.35e-05	0.000173	CcSEcCtD
Budesonide—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.34e-05	0.000172	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.34e-05	0.000172	CcSEcCtD
Budesonide—Infection—Gabapentin—epilepsy syndrome	4.34e-05	0.000172	CcSEcCtD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	4.33e-05	0.00722	CbGpPWpGaD
Budesonide—Muscle spasms—Topiramate—epilepsy syndrome	4.33e-05	0.000172	CcSEcCtD
Budesonide—Rash—Carbamazepine—epilepsy syndrome	4.32e-05	0.000172	CcSEcCtD
Budesonide—Dermatitis—Carbamazepine—epilepsy syndrome	4.32e-05	0.000171	CcSEcCtD
Budesonide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.31e-05	0.000171	CcSEcCtD
Budesonide—Insomnia—Pregabalin—epilepsy syndrome	4.31e-05	0.000171	CcSEcCtD
Budesonide—Nausea—Clonazepam—epilepsy syndrome	4.3e-05	0.00017	CcSEcCtD
Budesonide—Headache—Carbamazepine—epilepsy syndrome	4.3e-05	0.00017	CcSEcCtD
Budesonide—Shock—Gabapentin—epilepsy syndrome	4.3e-05	0.00017	CcSEcCtD
Budesonide—Nervous system disorder—Gabapentin—epilepsy syndrome	4.28e-05	0.00017	CcSEcCtD
Budesonide—Dexamethasone—NR3C1—epilepsy syndrome	4.28e-05	0.0084	CrCbGaD
Budesonide—Paraesthesia—Pregabalin—epilepsy syndrome	4.28e-05	0.00017	CcSEcCtD
Budesonide—Nausea—Phenytoin—epilepsy syndrome	4.27e-05	0.000169	CcSEcCtD
Budesonide—Tachycardia—Gabapentin—epilepsy syndrome	4.26e-05	0.000169	CcSEcCtD
Budesonide—Dyspnoea—Pregabalin—epilepsy syndrome	4.24e-05	0.000168	CcSEcCtD
Budesonide—Nausea—Oxcarbazepine—epilepsy syndrome	4.24e-05	0.000168	CcSEcCtD
Budesonide—Vision blurred—Topiramate—epilepsy syndrome	4.24e-05	0.000168	CcSEcCtD
Budesonide—Skin disorder—Gabapentin—epilepsy syndrome	4.24e-05	0.000168	CcSEcCtD
Budesonide—Somnolence—Pregabalin—epilepsy syndrome	4.23e-05	0.000168	CcSEcCtD
Budesonide—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.22e-05	0.000167	CcSEcCtD
Budesonide—Tremor—Topiramate—epilepsy syndrome	4.22e-05	0.000167	CcSEcCtD
Budesonide—Vomiting—Lamotrigine—epilepsy syndrome	4.21e-05	0.000167	CcSEcCtD
Budesonide—Urticaria—Valproic Acid—epilepsy syndrome	4.18e-05	0.000166	CcSEcCtD
Budesonide—Rash—Lamotrigine—epilepsy syndrome	4.18e-05	0.000166	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—epilepsy syndrome	4.18e-05	0.00696	CbGpPWpGaD
Budesonide—Ill-defined disorder—Topiramate—epilepsy syndrome	4.18e-05	0.000166	CcSEcCtD
Budesonide—Dermatitis—Lamotrigine—epilepsy syndrome	4.17e-05	0.000166	CcSEcCtD
Budesonide—Betamethasone—PTGS2—epilepsy syndrome	4.17e-05	0.0082	CrCbGaD
Budesonide—Abdominal pain—Valproic Acid—epilepsy syndrome	4.16e-05	0.000165	CcSEcCtD
Budesonide—Body temperature increased—Valproic Acid—epilepsy syndrome	4.16e-05	0.000165	CcSEcCtD
Budesonide—Anorexia—Gabapentin—epilepsy syndrome	4.16e-05	0.000165	CcSEcCtD
Budesonide—Anaemia—Topiramate—epilepsy syndrome	4.16e-05	0.000165	CcSEcCtD
Budesonide—Headache—Lamotrigine—epilepsy syndrome	4.15e-05	0.000165	CcSEcCtD
Budesonide—Decreased appetite—Pregabalin—epilepsy syndrome	4.14e-05	0.000164	CcSEcCtD
Budesonide—Agitation—Topiramate—epilepsy syndrome	4.14e-05	0.000164	CcSEcCtD
Budesonide—Prednisone—ALB—epilepsy syndrome	4.12e-05	0.00809	CrCbGaD
Budesonide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.11e-05	0.000163	CcSEcCtD
Budesonide—Fatigue—Pregabalin—epilepsy syndrome	4.1e-05	0.000163	CcSEcCtD
Budesonide—Nausea—Carbamazepine—epilepsy syndrome	4.07e-05	0.000162	CcSEcCtD
Budesonide—Pain—Pregabalin—epilepsy syndrome	4.07e-05	0.000162	CcSEcCtD
Budesonide—Constipation—Pregabalin—epilepsy syndrome	4.07e-05	0.000162	CcSEcCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—epilepsy syndrome	4.06e-05	0.00677	CbGpPWpGaD
Budesonide—Malaise—Topiramate—epilepsy syndrome	4.06e-05	0.000161	CcSEcCtD
Budesonide—Vertigo—Topiramate—epilepsy syndrome	4.04e-05	0.00016	CcSEcCtD
Budesonide—Syncope—Topiramate—epilepsy syndrome	4.04e-05	0.00016	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.98e-05	0.000158	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	3.98e-05	0.00663	CbGpPWpGaD
Budesonide—Palpitations—Topiramate—epilepsy syndrome	3.98e-05	0.000158	CcSEcCtD
Budesonide—Loss of consciousness—Topiramate—epilepsy syndrome	3.96e-05	0.000157	CcSEcCtD
Budesonide—Insomnia—Gabapentin—epilepsy syndrome	3.95e-05	0.000157	CcSEcCtD
Budesonide—Nausea—Lamotrigine—epilepsy syndrome	3.94e-05	0.000156	CcSEcCtD
Budesonide—Prednisone—ABCB1—epilepsy syndrome	3.93e-05	0.00772	CrCbGaD
Budesonide—Cough—Topiramate—epilepsy syndrome	3.93e-05	0.000156	CcSEcCtD
Budesonide—Feeling abnormal—Pregabalin—epilepsy syndrome	3.92e-05	0.000156	CcSEcCtD
Budesonide—Paraesthesia—Gabapentin—epilepsy syndrome	3.92e-05	0.000156	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	3.91e-05	0.00653	CbGpPWpGaD
Budesonide—Dexamethasone—CYP2C19—epilepsy syndrome	3.9e-05	0.00766	CrCbGaD
Budesonide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.89e-05	0.000154	CcSEcCtD
Budesonide—Dyspnoea—Gabapentin—epilepsy syndrome	3.89e-05	0.000154	CcSEcCtD
Budesonide—Hypertension—Topiramate—epilepsy syndrome	3.89e-05	0.000154	CcSEcCtD
Budesonide—Somnolence—Gabapentin—epilepsy syndrome	3.88e-05	0.000154	CcSEcCtD
Budesonide—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.88e-05	0.000154	CcSEcCtD
Budesonide—Dyspepsia—Gabapentin—epilepsy syndrome	3.84e-05	0.000152	CcSEcCtD
Budesonide—Myalgia—Topiramate—epilepsy syndrome	3.83e-05	0.000152	CcSEcCtD
Budesonide—Chest pain—Topiramate—epilepsy syndrome	3.83e-05	0.000152	CcSEcCtD
Budesonide—Arthralgia—Topiramate—epilepsy syndrome	3.83e-05	0.000152	CcSEcCtD
Budesonide—Anxiety—Topiramate—epilepsy syndrome	3.82e-05	0.000151	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.81e-05	0.000151	CcSEcCtD
Budesonide—Decreased appetite—Gabapentin—epilepsy syndrome	3.8e-05	0.000151	CcSEcCtD
Budesonide—Discomfort—Topiramate—epilepsy syndrome	3.79e-05	0.00015	CcSEcCtD
Budesonide—Urticaria—Pregabalin—epilepsy syndrome	3.78e-05	0.00015	CcSEcCtD
Budesonide—Asthenia—Valproic Acid—epilepsy syndrome	3.78e-05	0.00015	CcSEcCtD
Budesonide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.77e-05	0.00015	CcSEcCtD
Budesonide—Fatigue—Gabapentin—epilepsy syndrome	3.76e-05	0.000149	CcSEcCtD
Budesonide—Abdominal pain—Pregabalin—epilepsy syndrome	3.76e-05	0.000149	CcSEcCtD
Budesonide—Body temperature increased—Pregabalin—epilepsy syndrome	3.76e-05	0.000149	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	3.76e-05	0.00627	CbGpPWpGaD
Budesonide—Dry mouth—Topiramate—epilepsy syndrome	3.75e-05	0.000149	CcSEcCtD
Budesonide—Constipation—Gabapentin—epilepsy syndrome	3.73e-05	0.000148	CcSEcCtD
Budesonide—Pain—Gabapentin—epilepsy syndrome	3.73e-05	0.000148	CcSEcCtD
Budesonide—Pruritus—Valproic Acid—epilepsy syndrome	3.73e-05	0.000148	CcSEcCtD
Budesonide—Confusional state—Topiramate—epilepsy syndrome	3.7e-05	0.000147	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—AGT—epilepsy syndrome	3.65e-05	0.00609	CbGpPWpGaD
Budesonide—Infection—Topiramate—epilepsy syndrome	3.65e-05	0.000145	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—PLAU—epilepsy syndrome	3.63e-05	0.00605	CbGpPWpGaD
Budesonide—Prednisolone—ABCB1—epilepsy syndrome	3.62e-05	0.00711	CrCbGaD
Budesonide—Shock—Topiramate—epilepsy syndrome	3.61e-05	0.000143	CcSEcCtD
Budesonide—Diarrhoea—Valproic Acid—epilepsy syndrome	3.6e-05	0.000143	CcSEcCtD
Budesonide—Nervous system disorder—Topiramate—epilepsy syndrome	3.6e-05	0.000143	CcSEcCtD
Budesonide—Feeling abnormal—Gabapentin—epilepsy syndrome	3.6e-05	0.000143	CcSEcCtD
Budesonide—Tachycardia—Topiramate—epilepsy syndrome	3.58e-05	0.000142	CcSEcCtD
Budesonide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.57e-05	0.000142	CcSEcCtD
Budesonide—Skin disorder—Topiramate—epilepsy syndrome	3.57e-05	0.000142	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	3.55e-05	0.00593	CbGpPWpGaD
Budesonide—Hyperhidrosis—Topiramate—epilepsy syndrome	3.55e-05	0.000141	CcSEcCtD
Budesonide—Betamethasone—ABCB1—epilepsy syndrome	3.55e-05	0.00697	CrCbGaD
Budesonide—Hypersensitivity—Pregabalin—epilepsy syndrome	3.51e-05	0.000139	CcSEcCtD
Budesonide—Anorexia—Topiramate—epilepsy syndrome	3.5e-05	0.000139	CcSEcCtD
Budesonide—Dizziness—Valproic Acid—epilepsy syndrome	3.48e-05	0.000138	CcSEcCtD
Budesonide—Urticaria—Gabapentin—epilepsy syndrome	3.47e-05	0.000138	CcSEcCtD
Budesonide—Abdominal pain—Gabapentin—epilepsy syndrome	3.45e-05	0.000137	CcSEcCtD
Budesonide—Body temperature increased—Gabapentin—epilepsy syndrome	3.45e-05	0.000137	CcSEcCtD
Budesonide—Asthenia—Pregabalin—epilepsy syndrome	3.42e-05	0.000136	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	3.37e-05	0.00562	CbGpPWpGaD
Budesonide—Pruritus—Pregabalin—epilepsy syndrome	3.37e-05	0.000134	CcSEcCtD
Budesonide—Vomiting—Valproic Acid—epilepsy syndrome	3.35e-05	0.000133	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.35e-05	0.000133	CcSEcCtD
Budesonide—Insomnia—Topiramate—epilepsy syndrome	3.32e-05	0.000132	CcSEcCtD
Budesonide—Rash—Valproic Acid—epilepsy syndrome	3.32e-05	0.000132	CcSEcCtD
Budesonide—Dermatitis—Valproic Acid—epilepsy syndrome	3.32e-05	0.000132	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	3.3e-05	0.00551	CbGpPWpGaD
Budesonide—Headache—Valproic Acid—epilepsy syndrome	3.3e-05	0.000131	CcSEcCtD
Budesonide—Paraesthesia—Topiramate—epilepsy syndrome	3.3e-05	0.000131	CcSEcCtD
Budesonide—Dyspnoea—Topiramate—epilepsy syndrome	3.27e-05	0.00013	CcSEcCtD
Budesonide—Somnolence—Topiramate—epilepsy syndrome	3.27e-05	0.00013	CcSEcCtD
Budesonide—Diarrhoea—Pregabalin—epilepsy syndrome	3.26e-05	0.000129	CcSEcCtD
Budesonide—Dyspepsia—Topiramate—epilepsy syndrome	3.23e-05	0.000128	CcSEcCtD
Budesonide—Hypersensitivity—Gabapentin—epilepsy syndrome	3.22e-05	0.000128	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	3.21e-05	0.00536	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SST—epilepsy syndrome	3.21e-05	0.00536	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	3.2e-05	0.00533	CbGpPWpGaD
Budesonide—Decreased appetite—Topiramate—epilepsy syndrome	3.19e-05	0.000127	CcSEcCtD
Budesonide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.17e-05	0.000126	CcSEcCtD
Budesonide—Fatigue—Topiramate—epilepsy syndrome	3.17e-05	0.000126	CcSEcCtD
Budesonide—Dizziness—Pregabalin—epilepsy syndrome	3.15e-05	0.000125	CcSEcCtD
Budesonide—Pain—Topiramate—epilepsy syndrome	3.14e-05	0.000125	CcSEcCtD
Budesonide—Constipation—Topiramate—epilepsy syndrome	3.14e-05	0.000125	CcSEcCtD
Budesonide—Asthenia—Gabapentin—epilepsy syndrome	3.13e-05	0.000124	CcSEcCtD
Budesonide—Nausea—Valproic Acid—epilepsy syndrome	3.13e-05	0.000124	CcSEcCtD
Budesonide—Pruritus—Gabapentin—epilepsy syndrome	3.09e-05	0.000123	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	3.08e-05	0.00513	CbGpPWpGaD
Budesonide—Vomiting—Pregabalin—epilepsy syndrome	3.03e-05	0.00012	CcSEcCtD
Budesonide—Feeling abnormal—Topiramate—epilepsy syndrome	3.03e-05	0.00012	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	3.01e-05	0.00501	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Topiramate—epilepsy syndrome	3e-05	0.000119	CcSEcCtD
Budesonide—Rash—Pregabalin—epilepsy syndrome	3e-05	0.000119	CcSEcCtD
Budesonide—Dermatitis—Pregabalin—epilepsy syndrome	3e-05	0.000119	CcSEcCtD
Budesonide—Diarrhoea—Gabapentin—epilepsy syndrome	2.99e-05	0.000119	CcSEcCtD
Budesonide—Headache—Pregabalin—epilepsy syndrome	2.98e-05	0.000118	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	2.94e-05	0.00491	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	2.92e-05	0.00487	CbGpPWpGaD
Budesonide—Urticaria—Topiramate—epilepsy syndrome	2.92e-05	0.000116	CcSEcCtD
Budesonide—Abdominal pain—Topiramate—epilepsy syndrome	2.9e-05	0.000115	CcSEcCtD
Budesonide—Body temperature increased—Topiramate—epilepsy syndrome	2.9e-05	0.000115	CcSEcCtD
Budesonide—Dexamethasone—CYP2D6—epilepsy syndrome	2.89e-05	0.00568	CrCbGaD
Budesonide—Dizziness—Gabapentin—epilepsy syndrome	2.89e-05	0.000115	CcSEcCtD
Budesonide—Nausea—Pregabalin—epilepsy syndrome	2.83e-05	0.000112	CcSEcCtD
Budesonide—Vomiting—Gabapentin—epilepsy syndrome	2.78e-05	0.00011	CcSEcCtD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	2.77e-05	0.00462	CbGpPWpGaD
Budesonide—Hydrocortisone—ABCB1—epilepsy syndrome	2.77e-05	0.00544	CrCbGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	2.76e-05	0.0046	CbGpPWpGaD
Budesonide—Rash—Gabapentin—epilepsy syndrome	2.75e-05	0.000109	CcSEcCtD
Budesonide—Dermatitis—Gabapentin—epilepsy syndrome	2.75e-05	0.000109	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	2.74e-05	0.00457	CbGpPWpGaD
Budesonide—Headache—Gabapentin—epilepsy syndrome	2.73e-05	0.000109	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	2.71e-05	0.00452	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	2.71e-05	0.00451	CbGpPWpGaD
Budesonide—Hypersensitivity—Topiramate—epilepsy syndrome	2.71e-05	0.000107	CcSEcCtD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	2.64e-05	0.0044	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	2.64e-05	0.0044	CbGpPWpGaD
Budesonide—Asthenia—Topiramate—epilepsy syndrome	2.64e-05	0.000105	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	2.62e-05	0.00437	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	2.6e-05	0.00434	CbGpPWpGaD
Budesonide—Pruritus—Topiramate—epilepsy syndrome	2.6e-05	0.000103	CcSEcCtD
Budesonide—Nausea—Gabapentin—epilepsy syndrome	2.59e-05	0.000103	CcSEcCtD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	2.58e-05	0.00431	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	2.58e-05	0.0043	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	2.57e-05	0.00428	CbGpPWpGaD
Budesonide—Diarrhoea—Topiramate—epilepsy syndrome	2.51e-05	9.97e-05	CcSEcCtD
Budesonide—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	2.48e-05	0.00413	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	2.44e-05	0.00406	CbGpPWpGaD
Budesonide—Dizziness—Topiramate—epilepsy syndrome	2.43e-05	9.64e-05	CcSEcCtD
Budesonide—Dexamethasone—PTGS2—epilepsy syndrome	2.43e-05	0.00477	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	2.4e-05	0.004	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	2.35e-05	0.00392	CbGpPWpGaD
Budesonide—Vomiting—Topiramate—epilepsy syndrome	2.34e-05	9.27e-05	CcSEcCtD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	2.32e-05	0.00386	CbGpPWpGaD
Budesonide—Rash—Topiramate—epilepsy syndrome	2.32e-05	9.19e-05	CcSEcCtD
Budesonide—Dermatitis—Topiramate—epilepsy syndrome	2.31e-05	9.18e-05	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	2.3e-05	0.00384	CbGpPWpGaD
Budesonide—Headache—Topiramate—epilepsy syndrome	2.3e-05	9.13e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—WARS—epilepsy syndrome	2.27e-05	0.00379	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	2.23e-05	0.00371	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—AGT—epilepsy syndrome	2.23e-05	0.00371	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	2.22e-05	0.00371	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	2.21e-05	0.00368	CbGpPWpGaD
Budesonide—Nausea—Topiramate—epilepsy syndrome	2.18e-05	8.66e-05	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	2.15e-05	0.00359	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	2.15e-05	0.00358	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	2.13e-05	0.00355	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	2.13e-05	0.00355	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	2.12e-05	0.00354	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	2.11e-05	0.00352	CbGpPWpGaD
Budesonide—Dexamethasone—ABCB1—epilepsy syndrome	2.06e-05	0.00405	CrCbGaD
Budesonide—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	2.05e-05	0.00341	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	2.03e-05	0.00338	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	1.97e-05	0.00328	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	1.95e-05	0.00325	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	1.9e-05	0.00317	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	1.79e-05	0.00298	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—QARS—epilepsy syndrome	1.72e-05	0.00287	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	1.38e-05	0.00229	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	1.25e-05	0.00209	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TFAM—epilepsy syndrome	1.24e-05	0.00207	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	1.2e-05	0.002	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	1.2e-05	0.002	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	1.16e-05	0.00194	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.15e-05	0.00192	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.13e-05	0.00188	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.12e-05	0.00187	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.11e-05	0.00185	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.11e-05	0.00184	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	1.1e-05	0.00183	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	1.09e-05	0.00181	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	1.07e-05	0.00179	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.02e-05	0.0017	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.01e-05	0.00169	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—epilepsy syndrome	1.01e-05	0.00168	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	9.98e-06	0.00166	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	9.95e-06	0.00166	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	9.33e-06	0.00156	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	8.72e-06	0.00145	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA13—epilepsy syndrome	7.71e-06	0.00129	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	7.49e-06	0.00125	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	7.23e-06	0.00121	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—JUNB—epilepsy syndrome	6.03e-06	0.00101	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	5.85e-06	0.000975	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	5.85e-06	0.000975	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	5.85e-06	0.000975	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADK—epilepsy syndrome	5.85e-06	0.000975	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	5.85e-06	0.000975	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	5.85e-06	0.000975	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	5.35e-06	0.000891	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	5.35e-06	0.000891	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	5.35e-06	0.000891	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	5.35e-06	0.000891	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.97e-06	0.000829	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.97e-06	0.000829	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.96e-06	0.000826	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	4.86e-06	0.00081	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—VDR—epilepsy syndrome	4.79e-06	0.000798	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.67e-06	0.000779	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	4.54e-06	0.000757	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.43e-06	0.000739	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.43e-06	0.000739	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.43e-06	0.000739	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.43e-06	0.000739	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.43e-06	0.000739	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	4.38e-06	0.00073	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.05e-06	0.000676	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.05e-06	0.000676	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.05e-06	0.000676	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.9e-06	0.00065	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.77e-06	0.000628	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.77e-06	0.000628	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.54e-06	0.00059	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.45e-06	0.000574	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.36e-06	0.00056	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.36e-06	0.00056	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.2e-06	0.000534	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.2e-06	0.000534	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.13e-06	0.000523	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.07e-06	0.000512	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.01e-06	0.000502	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.96e-06	0.000493	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.77e-06	0.000461	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.68e-06	0.000448	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.43e-06	0.000405	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.43e-06	0.000405	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.98e-06	0.00033	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.93e-06	0.000322	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.92e-06	0.00032	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.73e-06	0.000288	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.65e-06	0.000275	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.64e-06	0.000273	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.56e-06	0.000261	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.55e-06	0.000258	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TH—epilepsy syndrome	1.54e-06	0.000257	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—epilepsy syndrome	1.32e-06	0.00022	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.29e-06	0.000215	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.27e-06	0.000212	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.24e-06	0.000206	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.15e-06	0.000191	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.01e-06	0.000168	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.86e-07	0.000164	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.47e-07	0.000141	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.73e-07	0.000129	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.76e-07	0.000113	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.4e-07	5.66e-05	CbGpPWpGaD
